WORLD PEPTIDEFOUNDATION
← Master Registry

Published peptide research references

Balixafortide

Governed registry record

4 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.

Approved source records

  1. At the Bedside: Profiling and treating patients with CXCR4-expressing cancers.

    DOI: 10.1002/jlb.5bt1219-714r

    Source identity and connection checked by Codex (AI).

  2. CXCR4 inhibitors: tumor vasculature and therapeutic challenges.

    DOI: 10.2174/157489212801820039PMID: 22376154

    Source identity and connection checked by Codex (AI).

  3. Clinical significance of chemokine receptor antagonists.

    DOI: 10.1080/17425255.2020.1711884PMID: 31903790

    Source identity and connection checked by Codex (AI).

  4. Targeting the CXCR4/CXCL12 Axis to Overcome Drug Resistance in Triple-Negative Breast Cancer.

    DOI: 10.3390/cells14181482

    Source identity and connection checked by Codex (AI).

Legacy research context

Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.

Researchers represented

  • Singh DD
  • Yadav DK
  • Shin D
  • Martin M
  • Mayer IA
  • Walenkamp AME
  • Lapa C
  • Andreeff M
  • Bobirca A
  • Miao M
  • De Clercq E
  • Li G
  • de Nigris F
  • Schiano C
  • Infante T
  • Napoli C